Rejuvenate Bio Announces Partnership with Leading Animal Health Company to Develop Gene Therapy for Canine Osteoarthritis [Yahoo! Finance]
Phibro Animal Health Corporation - Class A (PAHC)
Last phibro animal health corporation - class a earnings: 2/3 04:40 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.pahc.com/investor-relations
Company Research
Source: Yahoo! Finance
and commercialization of its novel gene therapy technology for the treatment of canine osteoarthritis (OA), a complex chronic disease that affects dogs' mobility and overall quality of life. This agreement with the global company follows the agreement reached in 2022 with Phibro Animal Health and further validates the gene therapy technology developed by Rejuvenate Bio and their strategy to develop their breakthrough technology in both animal health and human health. Canine osteoarthritis (OA) presents a significant challenge, being both painful and progressive, with a concerning prevalence rate. Studies indicate that OA affects more than 40% of dogs, suggesting a substantial number of the estimated 86 million dogs in U.S. households may be experiencing OA-related discomfort. Despite the widespread occurrence of OA in dogs, it is often under recognized and under-treated. Neglecting OA management can lead to heightened pain levels, decreased mobility, and a profound deterioration
Show less
Read more
Impact Snapshot
Event Time:
PAHC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PAHC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PAHC alerts
High impacting Phibro Animal Health Corporation - Class A news events
Weekly update
A roundup of the hottest topics
PAHC
News
- Zoetis (ZTS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Phibro Animal Health: An Interesting Deal With Zoetis For A Struggling Business [Seeking Alpha]Seeking Alpha
- Phibro (PAHC) Moves 31.8% Higher: Will This Strength Last? [Yahoo! Finance]Yahoo! Finance
- Zoetis to sell medicated feed additive portfolio to Phibro in $350 mln deal [Yahoo! Finance]Yahoo! Finance
- Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health [Yahoo! Finance]Yahoo! Finance
PAHC
Earnings
- 2/7/24 - Beat
PAHC
Sec Filings
- 4/29/24 - Form 8-K
- 3/5/24 - Form 144
- 2/14/24 - Form SC
- PAHC's page on the SEC website